Virax Biolabs Group Limited
Last updated September 27, 2026
Organization details
- Legal name
- Virax Biolabs Group Limited
- Former names
- Virax Biolabs (Cayman) Ltd
- Ownership
- Public
- Status
- Active
- SIC code
- 2835 — In Vitro & In Vivo Diagnostic Substances
- Jurisdiction of incorporation
- Cayman Islands
- Headquarters city
- Lanarkshire
- Headquarters country
- United Kingdom
- Fiscal year end
- March
- Ticker symbol
- VRAX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001885827
Board of directors
-
Evan Michael Norton · DirectorSince 2026
-
Iain David Miller · DirectorSince 2026
-
Nelson M. Haight · DirectorSince 2026
-
Nigel William McCracken · Director · Chief Operating OfficerSince 2026
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.